
Global Biopreservation Market Size Study & Forecast, by Product (Equipment, Media, LIMS) by Application (Regenerative Medicine, Bio-banking, Drug Discovery) and Regional Forecasts 2025-2035
Description
The Global Biopreservation Market is valued at approximately USD 3.59 billion in 2024 and is anticipated to expand at a remarkable CAGR of 28.30% over the forecast period 2025-2035. Biopreservation, at its core, refers to the process of maintaining the integrity and functionality of biological samples—such as cells, tissues, and organs—by leveraging specialized preservation techniques and solutions. This market has gained tremendous traction as the lifesciences ecosystem accelerates innovation, with research institutes, pharmaceutical giants, and biotechnology firms increasingly depending on preserved biospecimens for clinical trials, advanced therapeutics, and translational research. The surge in demand for personalized medicine, stem cell therapies, and regenerative treatments is fueling the adoption of biopreservation technologies, while increasing investment in advanced storage equipment and cryoprotective media further strengthens the market outlook.
The rising need for robust bio-banking solutions and the ongoing expansion of regenerative medicine research are catalyzing the global demand for biopreservation products. With an unprecedented volume of biological material being stored and utilized for drug discovery pipelines and personalized healthcare programs, laboratories and healthcare providers are racing to adopt reliable preservation methods that ensure sample viability over extended timeframes. For instance, the rising volume of stem cell transplants worldwide underscores the indispensability of biopreservation in modern medicine. In addition, the advent of AI-integrated Laboratory Information Management Systems (LIMS) and automation-driven cryogenic technologies is opening lucrative opportunities for the market, while the growing inclination toward decentralized clinical trials enhances the need for effective specimen management. However, the substantial costs of preservation equipment and stringent regulatory frameworks governing biospecimen handling may challenge the market’s growth trajectory during 2025-2035.
The detailed segments and sub-segments included in the report are:
By Product:
• Equipment
• Media
• LIMS
By Application:
• Regenerative Medicine
• Bio-banking
• Drug Discovery
By Region:
North America
• U.S.
• Canada
Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
Latin America
• Brazil
• Mexico
Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa
Regenerative medicine is projected to dominate the market, accounting for the largest share during the forecast period. The sector’s growth stems from the rising number of clinical trials focusing on stem cell and gene therapies, coupled with surging investments from both government and private entities to advance tissue engineering and cell therapy solutions. The strong emphasis on next-generation therapeutics for chronic illnesses and rare diseases has firmly positioned regenerative medicine at the forefront of biopreservation adoption. While bio-banking is also gaining significance due to the establishment of national and private biorepositories, regenerative medicine continues to lead as the primary revenue driver because of its transformative role in redefining healthcare solutions.
In terms of product categories, equipment currently holds the largest revenue share within the biopreservation market. Cryogenic freezers, liquid nitrogen systems, and advanced storage infrastructure remain essential for ensuring sample viability and scalability across large repositories. The demand for automated storage equipment has surged as healthcare institutions and research laboratories grapple with the complexities of storing vast biological datasets. Nevertheless, biopreservation media—designed to enhance sample stability and reduce cryoinjury—is expected to expand at the fastest CAGR over the forecast horizon, propelled by innovation in cryoprotective agents and customized formulations tailored to cell-specific requirements. Hence, while equipment dominates today in terms of sheer revenue, media emerges as the growth engine for the next decade.
The Global Biopreservation Market demonstrates varied growth dynamics across regions. North America has traditionally led the sector, driven by its strong research infrastructure, advanced healthcare system, and high adoption of regenerative medicine technologies. The region’s growing stem cell banking initiatives, combined with increased funding in precision medicine, cement its leadership position. Meanwhile, the Asia Pacific region is poised to experience the fastest growth, bolstered by rapid industrialization, expanding biotech clusters, and government-supported initiatives in China, India, and Japan to strengthen biobanking and clinical research. Europe continues to hold a significant market share due to the presence of robust pharmaceutical and biotechnology industries, whereas Latin America and the Middle East & Africa are gradually emerging as promising regions, supported by rising healthcare expenditure and growing interest in advanced therapeutic research.
Major market players included in this report are:
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Becton, Dickinson and Company
• BioLife Solutions Inc.
• PHC Holdings Corporation
• Lonza Group AG
• Chart Industries, Inc.
• Avantor, Inc.
• Corning Incorporated
• Cryoport, Inc.
• Brooks Life Sciences (Azenta Life Sciences)
• Precision BioLogic Inc.
• Stemcell Technologies Inc.
• VWR International, LLC (Avantor)
• LabVantage Solutions, Inc.
Global Biopreservation Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period - 2025-2035
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:
Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional-level analysis for each market segment.
• Detailed analysis of the geographical landscape with country-level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of the competitive structure of the market.
• Demand side and supply side analysis of the market.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
The rising need for robust bio-banking solutions and the ongoing expansion of regenerative medicine research are catalyzing the global demand for biopreservation products. With an unprecedented volume of biological material being stored and utilized for drug discovery pipelines and personalized healthcare programs, laboratories and healthcare providers are racing to adopt reliable preservation methods that ensure sample viability over extended timeframes. For instance, the rising volume of stem cell transplants worldwide underscores the indispensability of biopreservation in modern medicine. In addition, the advent of AI-integrated Laboratory Information Management Systems (LIMS) and automation-driven cryogenic technologies is opening lucrative opportunities for the market, while the growing inclination toward decentralized clinical trials enhances the need for effective specimen management. However, the substantial costs of preservation equipment and stringent regulatory frameworks governing biospecimen handling may challenge the market’s growth trajectory during 2025-2035.
The detailed segments and sub-segments included in the report are:
By Product:
• Equipment
• Media
• LIMS
By Application:
• Regenerative Medicine
• Bio-banking
• Drug Discovery
By Region:
North America
• U.S.
• Canada
Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
Latin America
• Brazil
• Mexico
Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa
Regenerative medicine is projected to dominate the market, accounting for the largest share during the forecast period. The sector’s growth stems from the rising number of clinical trials focusing on stem cell and gene therapies, coupled with surging investments from both government and private entities to advance tissue engineering and cell therapy solutions. The strong emphasis on next-generation therapeutics for chronic illnesses and rare diseases has firmly positioned regenerative medicine at the forefront of biopreservation adoption. While bio-banking is also gaining significance due to the establishment of national and private biorepositories, regenerative medicine continues to lead as the primary revenue driver because of its transformative role in redefining healthcare solutions.
In terms of product categories, equipment currently holds the largest revenue share within the biopreservation market. Cryogenic freezers, liquid nitrogen systems, and advanced storage infrastructure remain essential for ensuring sample viability and scalability across large repositories. The demand for automated storage equipment has surged as healthcare institutions and research laboratories grapple with the complexities of storing vast biological datasets. Nevertheless, biopreservation media—designed to enhance sample stability and reduce cryoinjury—is expected to expand at the fastest CAGR over the forecast horizon, propelled by innovation in cryoprotective agents and customized formulations tailored to cell-specific requirements. Hence, while equipment dominates today in terms of sheer revenue, media emerges as the growth engine for the next decade.
The Global Biopreservation Market demonstrates varied growth dynamics across regions. North America has traditionally led the sector, driven by its strong research infrastructure, advanced healthcare system, and high adoption of regenerative medicine technologies. The region’s growing stem cell banking initiatives, combined with increased funding in precision medicine, cement its leadership position. Meanwhile, the Asia Pacific region is poised to experience the fastest growth, bolstered by rapid industrialization, expanding biotech clusters, and government-supported initiatives in China, India, and Japan to strengthen biobanking and clinical research. Europe continues to hold a significant market share due to the presence of robust pharmaceutical and biotechnology industries, whereas Latin America and the Middle East & Africa are gradually emerging as promising regions, supported by rising healthcare expenditure and growing interest in advanced therapeutic research.
Major market players included in this report are:
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Becton, Dickinson and Company
• BioLife Solutions Inc.
• PHC Holdings Corporation
• Lonza Group AG
• Chart Industries, Inc.
• Avantor, Inc.
• Corning Incorporated
• Cryoport, Inc.
• Brooks Life Sciences (Azenta Life Sciences)
• Precision BioLogic Inc.
• Stemcell Technologies Inc.
• VWR International, LLC (Avantor)
• LabVantage Solutions, Inc.
Global Biopreservation Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period - 2025-2035
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:
Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional-level analysis for each market segment.
• Detailed analysis of the geographical landscape with country-level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of the competitive structure of the market.
• Demand side and supply side analysis of the market.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Table of Contents
285 Pages
- Chapter 1. Global Biopreservation Market Report Scope & Methodology
- 1.1. Research Objective
- 1.2. Research Methodology
- 1.2.1. Forecast Model
- 1.2.2. Desk Research
- 1.2.3. Top Down and Bottom-Up Approach
- 1.3. Research Attributes
- 1.4. Scope of the Study
- 1.4.1. Market Definition
- 1.4.2. Market Segmentation
- 1.5. Research Assumption
- 1.5.1. Inclusion & Exclusion
- 1.5.2. Limitations
- 1.5.3. Years Considered for the Study
- Chapter 2. Executive Summary
- 2.1. CEO/CXO Standpoint
- 2.2. Strategic Insights
- 2.3. ESG Analysis
- 2.4. key Findings
- Chapter 3. Global Biopreservation Market Forces Analysis
- 3.1. Market Forces Shaping The Global Biopreservation Market (2024-2035)
- 3.2. Drivers
- 3.2.1. Dependence on preserved biospecimens
- 3.2.2. Demand for personalized medicine, stem cell therapies, and regenerative treatments
- 3.3. Restraints
- 3.3.1. Costs of preservation equipment and stringent regulatory frameworks
- 3.4. Opportunities
- 3.4.1. Rising volume of stem cell transplants worldwide
- 3.4.2. Advent of AI-integrated Laboratory Information Management Systems (LIMS) and automation-driven cryogenic technologies
- Chapter 4. Global Spacer Fluid Industry Analysis
- 4.1. Porter’s 5 Forces Model
- 4.1.1. Bargaining Power of Buyer
- 4.1.2. Bargaining Power of Supplier
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.2. Porter’s 5 Force Forecast Model (2024-2035)
- 4.3. PESTEL Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
- 4.4. Top Investment Opportunities
- 4.5. Top Winning Strategies (2025)
- 4.6. Market Share Analysis (2024-2025)
- 4.7. Global Pricing Analysis And Trends 2025
- 4.8. Analyst Recommendation & Conclusion
- Chapter 5. Global Biopreservation Market Size & Forecasts by Product 2025-2035
- 5.1. Market Overview
- 5.2. Global Growth Hormone Deficiency Market Performance - Potential Analysis (2025)
- 5.3. Equipment
- 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.3.2. Market size analysis, by region, 2025-2035
- 5.4. Media
- 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.4.2. Market size analysis, by region, 2025-2035
- 5.5. LIMS
- 5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.5.2. Market size analysis, by region, 2025-2035
- Chapter 6. Global Biopreservation Market Size & Forecasts by Application 2025-2035
- 6.1. Market Overview
- 6.2. Global Growth Hormone Deficiency Market Performance - Potential Analysis (2025)
- 6.3. Regenerative Medicine
- 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.3.2. Market size analysis, by region, 2025-2035
- 6.4. Bio Banking
- 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.4.2. Market size analysis, by region, 2025-2035
- 6.5. Drug Discovery
- 6.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.5.2. Market size analysis, by region, 2025-2035
- Chapter 7. Global Biopreservation Market Size & Forecasts by Region 2025–2035
- 7.1. Growth Biopreservation Market, Regional Market Snapshot
- 7.2. Top Leading & Emerging Countries
- 7.3. North America Biopreservation Market
- 7.3.1. U.S. Biopreservation Market
- 7.3.1.1. Product breakdown size & forecasts, 2025-2035
- 7.3.1.2. Application breakdown size & forecasts, 2025-2035
- 7.3.2. Canada Biopreservation Market
- 7.3.2.1. Product breakdown size & forecasts, 2025-2035
- 7.3.2.2. Application breakdown size & forecasts, 2025-2035
- 7.4. Europe Biopreservation Market
- 7.4.1. UK Biopreservation Market
- 7.4.1.1. Product breakdown size & forecasts, 2025-2035
- 7.4.1.2. Application breakdown size & forecasts, 2025-2035
- 7.4.2. Germany Biopreservation Market
- 7.4.2.1. Product breakdown size & forecasts, 2025-2035
- 7.4.2.2. Application breakdown size & forecasts, 2025-2035
- 7.4.3. France Biopreservation Market
- 7.4.3.1. Product breakdown size & forecasts, 2025-2035
- 7.4.3.2. Application breakdown size & forecasts, 2025-2035
- 7.4.4. Spain Biopreservation Market
- 7.4.4.1. Product breakdown size & forecasts, 2025-2035
- 7.4.4.2. Application breakdown size & forecasts, 2025-2035
- 7.4.5. Italy Biopreservation Market
- 7.4.5.1. Product breakdown size & forecasts, 2025-2035
- 7.4.5.2. Application breakdown size & forecasts, 2025-2035
- 7.4.6. Rest of Europe Biopreservation Market
- 7.4.6.1. Product breakdown size & forecasts, 2025-2035
- 7.4.6.2. Application breakdown size & forecasts, 2025-2035
- 7.5. Asia Pacific Biopreservation Market
- 7.5.1. China Biopreservation Market
- 7.5.1.1. Product breakdown size & forecasts, 2025-2035
- 7.5.1.2. Application breakdown size & forecasts, 2025-2035
- 7.5.2. India Biopreservation Market
- 7.5.2.1. Product breakdown size & forecasts, 2025-2035
- 7.5.2.2. Application breakdown size & forecasts, 2025-2035
- 7.5.3. Japan Biopreservation Market
- 7.5.3.1. Product breakdown size & forecasts, 2025-2035
- 7.5.3.2. Application breakdown size & forecasts, 2025-2035
- 7.5.4. Australia Biopreservation Market
- 7.5.4.1. Product breakdown size & forecasts, 2025-2035
- 7.5.4.2. Application breakdown size & forecasts, 2025-2035
- 7.5.5. South Korea Biopreservation Market
- 7.5.5.1. Product breakdown size & forecasts, 2025-2035
- 7.5.5.2. Application breakdown size & forecasts, 2025-2035
- 7.5.6. Rest of APAC Biopreservation Market
- 7.5.6.1. Product breakdown size & forecasts, 2025-2035
- 7.5.6.2. Application breakdown size & forecasts, 2025-2035
- 7.6. Latin America Biopreservation Market
- 7.6.1. Brazil Biopreservation Market
- 7.6.1.1. Product breakdown size & forecasts, 2025-2035
- 7.6.1.2. Application breakdown size & forecasts, 2025-2035
- 7.6.2. Mexico Biopreservation Market
- 7.6.2.1. Product breakdown size & forecasts, 2025-2035
- 7.6.2.2. Application breakdown size & forecasts, 2025-2035
- 7.7. Middle East and Africa Biopreservation Market
- 7.7.1. UAE Biopreservation Market
- 7.7.1.1. Product breakdown size & forecasts, 2025-2035
- 7.7.1.2. Application breakdown size & forecasts, 2025-2035
- 7.7.2. Saudi Arabia (KSA) Biopreservation Market
- 7.7.2.1. Product breakdown size & forecasts, 2025-2035
- 7.7.2.2. Application breakdown size & forecasts, 2025-2035
- 7.7.3. South Africa Biopreservation Market
- 7.7.3.1. Product breakdown size & forecasts, 2025-2035
- 7.7.3.2. Application breakdown size & forecasts, 2025-2035
- Chapter 8. Competitive Intelligence
- 8.1. Top Market Strategies
- 8.2. Thermo Fisher Scientific Inc.
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Financial Performance (Subject to Data Availability)
- 8.2.5. Product/Services Port
- 8.2.6. Recent Development
- 8.2.7. Market Strategies
- 8.2.8. SWOT Analysis
- 8.3. Merck KGaA
- 8.4. Becton, Dickinson and Company
- 8.5. BioLife Solutions Inc.
- 8.6. PHC Holdings Corporation
- 8.7. Lonza Group AG
- 8.8. Chart Industries, Inc.
- 8.9. Avantor, Inc.
- 8.10. Corning Incorporated
- 8.11. Cryoport, Inc.
- 8.12. Brooks Life Sciences (Azenta Life Sciences)
- 8.13. Precision BioLogic Inc.
- 8.14. Stemcell Technologies Inc.
- 8.15. VWR International, LLC (Avantor)
- 8.16. LabVantage Solutions
- List of Tables
- Table 1. Global Biopreservation Market, Report Scope
- Table 2. Global Biopreservation Market Estimates & Forecasts By Region 2024–2035
- Table 3. Global Biopreservation Market Estimates & Forecasts By Segment 2024–2035
- Table 4. Global Biopreservation Market Estimates & Forecasts By Segment 2024–2035
- Table 5. Global Biopreservation Market Estimates & Forecasts By Segment 2024–2035
- Table 6. Global Biopreservation Market Estimates & Forecasts By Segment 2024–2035
- Table 7. Global Biopreservation Market Estimates & Forecasts By Segment 2024–2035
- Table 8. U.S. Biopreservation Market Estimates & Forecasts, 2024–2035
- Table 9. Canada Biopreservation Market Estimates & Forecasts, 2024–2035
- Table 10. UK Biopreservation Market Estimates & Forecasts, 2024–2035
- Table 11. Germany Biopreservation Market Estimates & Forecasts, 2024–2035
- Table 12. France Biopreservation Market Estimates & Forecasts, 2024–2035
- Table 13. Spain Biopreservation Market Estimates & Forecasts, 2024–2035
- Table 14. Italy Biopreservation Market Estimates & Forecasts, 2024–2035
- Table 15. Rest Of Europe Biopreservation Market Estimates & Forecasts, 2024–2035
- Table 16. China Biopreservation Market Estimates & Forecasts, 2024–2035
- Table 17. India Biopreservation Market Estimates & Forecasts, 2024–2035
- Table 18. Japan Biopreservation Market Estimates & Forecasts, 2024–2035
- Table 19. Australia Biopreservation Market Estimates & Forecasts, 2024–2035
- Table 20. South Korea Biopreservation Market Estimates & Forecasts, 2024–2035
- List of Figures
- Fig 1. Global Biopreservation Market, Research Methodology
- Fig 2. Global Biopreservation Market, Market Estimation Techniques
- Fig 3. Global Market Size Estimates & Forecast Methods
- Fig 4. Global Biopreservation Market, Key Trends 2025
- Fig 5. Global Biopreservation Market, Growth Prospects 2024–2035
- Fig 6. Global Biopreservation Market, Porter’s Five Forces Model
- Fig 7. Global Biopreservation Market, Pestel Analysis
- Fig 8. Global Biopreservation Market, Value Chain Analysis
- Fig 9. Biopreservation Market By Application, 2025 & 2035
- Fig 10. Biopreservation Market By Segment, 2025 & 2035
- Fig 11. Biopreservation Market By Segment, 2025 & 2035
- Fig 12. Biopreservation Market By Segment, 2025 & 2035
- Fig 13. Biopreservation Market By Segment, 2025 & 2035
- Fig 14. North America Biopreservation Market, 2025 & 2035
- Fig 15. Europe Biopreservation Market, 2025 & 2035
- Fig 16. Asia Pacific Biopreservation Market, 2025 & 2035
- Fig 17. Latin America Biopreservation Market, 2025 & 2035
- Fig 18. Middle East & Africa Biopreservation Market, 2025 & 2035
- Fig 19. Global Biopreservation Market, Company Market Share Analysis (2025)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.